A Postoperative Sore Throat After Thyroidectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

74 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-05

Study Completion Date

2018-07-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was performed to compare the effect on of a postoperative sore throat between dexmedetomidine and remifentanil in patients undergoing thyroidectomy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Antitussive Effect of Single-dose Dexmedetomidine With Low-dose Remifentanil Infusion

NCT02208505

Thyroidectomy

COMPLETED PHASE4

A Postoperative Sore Throat After Lumbar Spine Surgery in the Prone Position

NCT05345574

Post Operative Sore Throat

UNKNOWN NA

Effect of Dexmedetomidine After Thyroidectomy

NCT02412150

Thyroid Tumor

COMPLETED NA

Intravenous Lidocaine Plus Intratracheal Dexmedetomidine on Postoperative Sore Throat

NCT06952309

Dexmedetomidine Lidocaine Sore Throat

NOT_YET_RECRUITING NA

Effects of Dexmedetomidine on Cough Response and Postoperative Recovery Quality in Patients Undergoing Thyroid Surgery With General Anesthesia

NCT02613806

Coughing Response Thyroid Surgery General Anesthesia

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post Operative Sore Throat

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

dexmedetomidine infusion group

dexmedetomidine infusion (loading dose of 1 ㎍/kg over 10 min and continuous infusion of 0.3-0.6 ㎍/kg/h) during the surgery

Group Type ACTIVE_COMPARATOR

dexmedetomidine infusion group

Intervention Type DRUG

dexmedetomidine as anaesthetic adjuvant

remifentanil infusion group

remifentanil of 4 ng/ml during induction, followed by remifentanil infusion (1.5\~2.5 ng/ml) during the surgery

Group Type ACTIVE_COMPARATOR

remifentanil infusion group

Intervention Type DRUG

remifentanil as anaesthetic adjuvant

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dexmedetomidine infusion group

dexmedetomidine as anaesthetic adjuvant

Intervention Type DRUG

remifentanil infusion group

remifentanil as anaesthetic adjuvant

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who scheduled primary thyroidectomy were enrolled and their physical status was American Society of Anesthesiologists (ASA) class 1 or 2

Exclusion Criteria

* Patients with respiratory tract disease, previous head, and neck surgery, preexisting steroid or non-steroidal anti-inflammatory drug use, and known or suspected difficult airway

Minimum Eligible Age

20 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No